BURLINGTON, Mass., May 12, 2014 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO) announced today its financial results for the first quarter ended March 31, 2014. "We are making progress on multiple fronts," said Dr. Lindsay A. Rosenwald, Coronado's Chairman, President and CEO. "While we continue to invest in TSO and the NK program, we have also begun pursuing business development opportunities in line with our growth strategy."
Help employers find you! Check out all the jobs and post your resume.
